SE8704272L - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
SE8704272L
SE8704272L SE8704272A SE8704272A SE8704272L SE 8704272 L SE8704272 L SE 8704272L SE 8704272 A SE8704272 A SE 8704272A SE 8704272 A SE8704272 A SE 8704272A SE 8704272 L SE8704272 L SE 8704272L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
dithia
azaspiro
alanyl
phenylpropyl
Prior art date
Application number
SE8704272A
Other languages
Swedish (sv)
Other versions
SE8704272D0 (en
Inventor
H Siegl
R P Hof
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8704272D0 publication Critical patent/SE8704272D0/en
Publication of SE8704272L publication Critical patent/SE8704272L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical composition for use against hypertension and congestive heart failure containing a) A calcium antagonist and b) the ACE-inhibitor 7-(N-¢1-(S)-Ethoxycarbonyl-3-phenylpropyl!-(S)-alanyl)-1,4-dithia-7-azaspiro-¢4,4!nonane-8-(S)-carboxylic acid.
SE8704272A 1986-11-03 1987-11-02 PHARMACEUTICAL COMPOSITION SE8704272L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE8704272D0 SE8704272D0 (en) 1987-11-02
SE8704272L true SE8704272L (en) 1988-05-04

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704272A SE8704272L (en) 1986-11-03 1987-11-02 PHARMACEUTICAL COMPOSITION

Country Status (25)

Country Link
KR (1) KR960005145B1 (en)
AT (1) AT397343B (en)
AU (1) AU615883B2 (en)
BE (1) BE1002063A4 (en)
CA (1) CA1314222C (en)
CH (1) CH677189A5 (en)
DE (1) DE3736505A1 (en)
DK (1) DK574087A (en)
ES (1) ES2010524A6 (en)
FI (1) FI874823A (en)
FR (1) FR2605885B1 (en)
GR (1) GR871680B (en)
HK (1) HK138893A (en)
HU (1) HU199681B (en)
IE (1) IE60496B1 (en)
IL (1) IL84343A (en)
IT (1) IT1212037B (en)
LU (1) LU87034A1 (en)
MY (1) MY102124A (en)
NL (1) NL8702502A (en)
NO (1) NO874539L (en)
NZ (1) NZ222401A (en)
PH (1) PH23249A (en)
PT (1) PT86062B (en)
SE (1) SE8704272L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (en) * 1988-05-28 1989-12-07 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH COLD CHANNEL MODULATORS AND THEIR USE IN MEDICINAL PRODUCTS
FR2733911B1 (en) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION FOR RENAL OR CARDIOVASCULAR DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (en) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen COMBINATION OF DIHYDROPYRIDINE WITH ACE INHIBITORS AND THEIR USE IN MEDICINAL PRODUCTS
DE3633496A1 (en) * 1986-10-02 1988-04-14 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH CALCIUMANTAGONISTS AND THEIR USE IN MEDICINAL PRODUCTS
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HU199681B (en) 1990-03-28
HUT47847A (en) 1989-04-28
IT8748553A0 (en) 1987-10-30
ES2010524A6 (en) 1989-11-16
PH23249A (en) 1989-06-16
CH677189A5 (en) 1991-04-30
KR960005145B1 (en) 1996-04-22
SE8704272D0 (en) 1987-11-02
PT86062A (en) 1987-12-01
FR2605885A1 (en) 1988-05-06
KR880006197A (en) 1988-07-22
DK574087A (en) 1988-05-04
DE3736505A1 (en) 1988-05-05
LU87034A1 (en) 1988-05-03
FI874823A (en) 1988-05-04
AU8057687A (en) 1988-05-05
PT86062B (en) 1990-11-07
AT397343B (en) 1994-03-25
NO874539D0 (en) 1987-11-02
FR2605885B1 (en) 1993-09-10
CA1314222C (en) 1993-03-09
FI874823A0 (en) 1987-11-02
NL8702502A (en) 1988-06-01
IE60496B1 (en) 1994-07-27
GR871680B (en) 1988-05-02
IL84343A (en) 1993-07-08
IT1212037B (en) 1989-11-08
ATA286987A (en) 1993-08-15
IL84343A0 (en) 1990-02-09
DK574087D0 (en) 1987-11-02
NZ222401A (en) 1991-04-26
BE1002063A4 (en) 1990-06-12
MY102124A (en) 1992-03-31
IE872951L (en) 1988-05-03
AU615883B2 (en) 1991-10-17
HK138893A (en) 1993-12-24
NO874539L (en) 1988-05-04

Similar Documents

Publication Publication Date Title
SG52709A1 (en) Substituted imidazoles
BG103143A (en) Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives
NO900264L (en) PROCEDURE FOR THE PREPARATION OF A COMBINATION OF BETA-BLOCKING / ANGIOTENSIN II-BLOCKING ANTIHYPERTENSIVE AGENTS.
IT1187643B (en) 1- (IDROSSOMETIL) -1,6,7,11B-TETRAIDRO-2H- (1,3) OSSAZINO-OR-TIAZINO (4,3-A) ISOCHINOLIN-DE RIVATI, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN
UA26845C2 (en) The derivatives of peptides, which are antagonists of substance p and neurokinin a
AU576550B2 (en) Substituted hexahydro arylquinolizines
SE8704272L (en) PHARMACEUTICAL COMPOSITION
BR9714376A (en) Somatostatin antagonists
GR862285B (en) Pharmaceutical compositions for treating the high blood pressure
IE812399L (en) Benzodioxines
DK0609242T3 (en) New thrombin inhibitory protein from blood mites
GB2198641B (en) Pharmaceutical composition for use against hypertension and congestive heart failure
DK541789A (en) PHARMACEUTICAL PREPARATION CONTAINING 5-T-BUTYL-3-OEN- (1- (S) -ETHOXYCARBONYL-3-PHENYLPROPYL) -L-ALANYLAA-2,3-DIHYDRO-1,3,4-THIADIAZOL-2- (S) -CARBOXYLIC ACID OR DERIVATIVES THEREOF, AND PROCEDURE FOR ITS PREPARATION
FI893211A (en) ANTIHYPERTENSIVE, N-TERMINAL ETHERAMINODIOLAMINO SYRADERIVES.
GB9014705D0 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
CY1702A (en) Pharmaceutical composition for use against hypertension and congestive heart failure
DK153473C (en) (1-PHENETHYL) -ALFA-PHENYL-PIPERIDINE-3-PROPANNITRIL DERIVATIVES AND MEDICINE USED AS CALCIUM ANTAGONIST AND AS ANTIHYPERTENSIVE AGENT
IT8619931A0 (en) PROCEDURE FOR THE PREPARATION OF 1-(N-METHYLAMIDINO)-3-(2,6-DIMETHYLPHE NIL) UREA AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS.